ConductScience.org, home

Paper4563045

1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.

Carter SK and 3 others. Adv Cancer Res, 1972. Cited by 104 papers, by iCite.

Cite this record

ConductScience Library. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review. Papers, record 4563045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4563045

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
PubMed
Journal
Adv Cancer Res
PubMed
Year
1972
PubMed
Publication types
Clinical Trial, Journal Article, Review
PubMed
Citations, by iCite
104
iCite
Relative citation ratio, by iCite
3.49
iCite
Revised in PubMed
2019-10-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carter SKS K
2Schabel FM JrF M
3Broder LEL E
4Johnston TPT P

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
CarmustineMajor topic
NeoplasmsMajor topic
Nitrosourea CompoundsMajor topic
Adenocarcinoma
Animals
Carcinoma
Cell Line
Cell-Free System
Chemical Phenomena
Chemistry
Clinical Trials as Topic
Cricetinae
Humans
Leukemia L1210
Lung Neoplasms
Mice
Mice, Inbred Strains
National Institutes of Health (U.S.)
Neoplasm Transplantation
Neoplasms, Experimental
Rats
Sarcoma, Experimental
Structure-Activity Relationship
United States

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.

PMIDTitleJournalYearIn PapersSource
37612719A multi-functional hypoxia/esterase dual stimulus responsive and hyaluronic acid-based nanomicelle for targeting delivery of chloroethylnitrosouea.J Nanobiotechnology2023https://conductscience.org/library/papers/37612719PubMed
27471070Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes.Sci Rep2016https://conductscience.org/library/papers/27471070PubMed
21380568HPLC method validation for the quantification of lomustine to study pharmacokinetics of thermosensitive liposome-encapsulated lomustine containing iohexol for CT imaging in C6 glioma rats.Eur J Drug Metab Pharmacokinet2011https://conductscience.org/library/papers/21380568PubMed
18472995Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.Ther Clin Risk Manag2007https://conductscience.org/library/papers/18472995PubMed
11349876Antitumor efficacy of SarCNU in a human glioma xenograft model expressing both MGMT and extraneuronal monoamine transporter.J Neurooncol2001https://conductscience.org/library/papers/11349876PubMed
10582663Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model.J Neurooncol1999https://conductscience.org/library/papers/10582663PubMed
8552605Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8552605PubMed
8507720MCNU in the treatment of essential thrombocythemia--a pilot study.Ann Hematol1993https://conductscience.org/library/papers/8507720PubMed
8500228Effect of O6-benzylguanine on the response to 1,3-bis(2-chloroethyl)-1-nitrosourea in the Dunning R3327G model of prostatic cancer.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8500228PubMed
8226282Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice.Jpn J Cancer Res1993https://conductscience.org/library/papers/8226282PubMed
7002528Cancer chemotherapy: new developments and changing concepts.Drugs1980https://conductscience.org/library/papers/7002528PubMed
6954016
Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)].
Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6954016PubMed
6852549Histopathologic changes following carmustine treatment of uveal Greene melanoma in rabbits.Graefes Arch Clin Exp Ophthalmol1983https://conductscience.org/library/papers/6852549PubMed
6603303
Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis.
Clin Exp Immunol1983https://conductscience.org/library/papers/6603303PubMed
6235230The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.J Cancer Res Clin Oncol1984https://conductscience.org/library/papers/6235230PubMed
6222844Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6222844PubMed
6189661Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6189661PubMed
4085418Repair of O6-(2-chloroethyl)guanine mediates the biological effects of chloroethylnitrosoureas.Environ Health Perspect1985https://conductscience.org/library/papers/4085418PubMed
4077917Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.J Cancer Res Clin Oncol1985https://conductscience.org/library/papers/4077917PubMed
3949853
Comparison of DNA damage in various tissues, myelosuppression and serum levels of transaminases and bilirubin in tumor-bearing female Sprague-Dawley rats treated with 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea (HECNU).
J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/3949853PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4563045

GET https://conductscience.org/api/papers/v1/4563045/cited_by?page=2